Patient preferences in managing zinc deficiency in celiac disease: Insights to inform future clinical trial design
Nutrition and Health · 02.03.2026
DOI: 10.1177/02601060261425465 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrition and Health, online erschienen am 02.03.2026. Verfasst von Anil K Verma und 7 weiteren Autor:innen. Beteiligte Einrichtung: Farncombe Family Digestive Health Research Institute, Department of Medicine, McMaster University, Hamilton, ON, Canada. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Zinc deficiency (ZD) is one of the most prevalent nutritional deficiencies reported in celiac disease (CeD). Oral supplementation and dietary modifications are the primary strategies for addressing it. However, it is unclear whether individuals with CeD would prefer to make additional dietary modifications or opt for supplementation to treat ZD.
Aim
This study aimed to explore patient preferences for the treatment of ZD.
Methods
Adult patients (≥18 years) with a confirmed diagnosis of CeD who were already adopting a gluten-free diet (GFD) and had untreated ZD were recruited from the Adult Celiac Disease Clinic at McMaster University. After providing informed consent, participants completed study questionnaires at baseline and three months after initiating zinc supplementation. Data were collected using REDCap. Statistical analyses were performed using IBM SPSS software (V22, Chicago, USA).
Results
From March 2022 to January 2024, 44 participants were enrolled in the study. All completed baseline questionnaires, of them 25 (57%) completed questionnaires at follow-up. At baseline, 34% of participants preferred to treat nutrient deficiencies through dietary changes, compared with 28% at follow-up. Plasma zinc level normalized in all participants after 3 months of supplementation. At follow-up, the proportion of participants with significant gastrointestinal symptoms increased from 72% at baseline to 80% ( p = 0 . 01).
Conclusions
One-third of patients with CeD preferred to manage nutrient deficiencies through dietary modifications. A zinc-optimized GFD may represent a promising approach to address zinc deficiency in this population. These findings provide preliminary evidence to inform the design of future randomized clinical trials.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Farncombe Family Digestive Health Research Institute, Department of Medicine, McMaster University, Hamilton, ON, Canada.
- Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
- Department of Medicine, McMaster University, Hamilton, ON, Canada.
- Digestive Diseases Clinic, Hamilton Health Sciences, Hamilton, ON, Canada.
- Department of Gastroenterology, Hepatology, and Nutrition, Cleveland Clinic, Cleveland, OH, USA.
ORCID-Profile: Anil K Verma, Jedid-Jah Blom, David Armstrong, Maria Ines Pinto-Sanchez
Zitieren
APA
Verma, A. K., Tandon, S., Graham, K., Blom, J. J., Russell, L., Morgan, J., Armstrong, D., & Pinto-Sanchez, M. I. (2026). Patient preferences in managing zinc deficiency in celiac disease: Insights to inform future clinical trial design. Nutrition and Health. https://doi.org/10.1177/02601060261425465
Vancouver
Verma AK, Tandon S, Graham K, Blom JJ, Russell L, Morgan J, et al. Patient preferences in managing zinc deficiency in celiac disease: Insights to inform future clinical trial design. Nutrition and Health. 2026. doi:10.1177/02601060261425465
BibTeX
@article{Verma2026,
author = {Verma, Anil K and Tandon, Shilpa and Graham, Kennedy and Blom, Jedid-Jah and Russell, Lindsey and Morgan, Jane and Armstrong, David and Pinto-Sanchez, Maria Ines},
title = {Patient preferences in managing zinc deficiency in celiac disease: Insights to inform future clinical trial design},
journal = {Nutrition and Health},
year = {2026},
doi = {10.1177/02601060261425465}
}
EUVIMED